BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 28710180)

  • 1. Dipeptidyl Peptidase-4 Regulates Hematopoietic Stem Cell Activation in Response to Chronic Stress.
    Zhu E; Hu L; Wu H; Piao L; Zhao G; Inoue A; Kim W; Yu C; Xu W; Bando YK; Li X; Lei Y; Hao CN; Takeshita K; Kim WS; Okumura K; Murohara T; Kuzuya M; Cheng XW
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic Psychological Stress Accelerates Vascular Senescence and Impairs Ischemia-Induced Neovascularization: The Role of Dipeptidyl Peptidase-4/Glucagon-Like Peptide-1-Adiponectin Axis.
    Piao L; Zhao G; Zhu E; Inoue A; Shibata R; Lei Y; Hu L; Yu C; Yang G; Wu H; Xu W; Okumura K; Ouchi N; Murohara T; Kuzuya M; Cheng XW
    J Am Heart Assoc; 2017 Sep; 6(10):. PubMed ID: 28963101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of DPP4 enhances inhibitory synaptic transmission through activating the GLP-1/GLP-1R signaling pathway in a rat model of febrile seizures.
    Zhang Y; Liu Y; Xu J; Sun Q; Yu F; Cheng J; Peng B; Liu W; Xiao Z; Yin J; Han S; He X
    Biochem Pharmacol; 2018 Oct; 156():78-85. PubMed ID: 30086287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidyl peptidase-4 disturbs adipocyte differentiation via the negative regulation of the glucagon-like peptide-1/adiponectin-cathepsin K axis in mice under chronic stress conditions.
    Zhang M; Yue X; Xu S; Piao J; Zhao L; Shu S; Kuzuya M; Li P; Hong L; Kim W; Liu B; Cheng XW
    FASEB J; 2024 May; 38(10):e23684. PubMed ID: 38795334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native, Intact Glucagon-Like Peptide 1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions.
    Sternkopf M; Nagy M; Baaten CCFMJ; Kuijpers MJE; Tullemans BME; Wirth J; Theelen W; Mastenbroek TG; Lehrke M; Winnerling B; Baerts L; Marx N; De Meester I; Döring Y; Cosemans JMEM; Daiber A; Steven S; Jankowski J; Heemskerk JWM; Noels H
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):e65-e77. PubMed ID: 31893947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased dipeptidyl peptidase-4 accelerates diet-related vascular aging and atherosclerosis in ApoE-deficient mice under chronic stress.
    Lei Y; Yang G; Hu L; Piao L; Inoue A; Jiang H; Sasaki T; Zhao G; Yisireyili M; Yu C; Xu W; Takeshita K; Okumura K; Kuzuya M; Cheng XW;
    Int J Cardiol; 2017 Sep; 243():413-420. PubMed ID: 28549747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase.
    Ben-Shlomo S; Zvibel I; Shnell M; Shlomai A; Chepurko E; Halpern Z; Barzilai N; Oren R; Fishman S
    J Hepatol; 2011 Jun; 54(6):1214-23. PubMed ID: 21145820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of intestinal growth and function with DPP4 inhibition in a mouse short bowel syndrome model.
    Sueyoshi R; Woods Ignatoski KM; Okawada M; Hartmann B; Holst J; Teitelbaum DH
    Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(4):G410-9. PubMed ID: 24970775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel multi-epitope vaccine based on Dipeptidyl Peptidase 4 prevents streptozotocin-induced diabetes by producing anti-DPP4 antibody and immunomodulatory effect in C57BL/6J mice.
    Li Z; Fang J; Jiao R; Wei X; Ma Y; Liu X; Cheng P; Li T
    Biomed Pharmacother; 2017 May; 89():1467-1475. PubMed ID: 28376584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptidyl peptidase-4 inhibition prevents lung injury in mice under chronic stress via the modulation of oxidative stress and inflammation.
    Zhang S; Li P; Xin M; Jin X; Zhao L; Nan Y; Cheng XW
    Exp Anim; 2021 Nov; 70(4):541-552. PubMed ID: 34219073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal regulation of urinary sodium excretion and the pathophysiology of diabetic kidney disease: a focus on glucagon-like peptide 1 and dipeptidyl peptidase 4.
    Vallon V; Docherty NG
    Exp Physiol; 2014 Sep; 99(9):1140-5. PubMed ID: 25085841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipeptidyl Peptidase-4 Inhibitor Anagliptin Prevents Intracranial Aneurysm Growth by Suppressing Macrophage Infiltration and Activation.
    Ikedo T; Minami M; Kataoka H; Hayashi K; Nagata M; Fujikawa R; Higuchi S; Yasui M; Aoki T; Fukuda M; Yokode M; Miyamoto S
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28630262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dipeptidyl peptidase 4 inhibition on arterial blood pressure is context dependent.
    Jackson EK; Mi Z; Tofovic SP; Gillespie DG
    Hypertension; 2015 Jan; 65(1):238-49. PubMed ID: 25368027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl Peptidase 4 Inhibition Ameliorates Chronic Kidney Disease in a Model of Salt-Dependent Hypertension.
    Cappetta D; Ciuffreda LP; Cozzolino A; Esposito G; Scavone C; Sapio L; Naviglio S; D'Amario D; Crea F; Rossi F; Berrino L; De Angelis A; Urbanek K
    Oxid Med Cell Longev; 2019; 2019():8912768. PubMed ID: 30774748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DPP4 deficiency preserves cardiac function via GLP-1 signaling in rats subjected to myocardial ischemia/reperfusion.
    Ku HC; Chen WP; Su MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Aug; 384(2):197-207. PubMed ID: 21748358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury.
    Ihara M; Asanuma H; Yamazaki S; Kato H; Asano Y; Shinozaki Y; Mori H; Minamino T; Asakura M; Sugimachi M; Mochizuki N; Kitakaze M
    Am J Physiol Heart Circ Physiol; 2015 May; 308(10):H1287-97. PubMed ID: 25747753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose rectification of an imbalance between DPP4 and GLP-1 ameliorates chronic stress-related vascular aging and atherosclerosis?
    Cheng XW; Narisawa M; Jin E; Yu C; Xu W; Piao L
    Clin Exp Pharmacol Physiol; 2018 May; 45(5):467-470. PubMed ID: 29220092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl Peptidase 4 Inhibition Alleviates Shortage of Circulating Glucagon-Like Peptide-1 in Heart Failure and Mitigates Myocardial Remodeling and Apoptosis via the Exchange Protein Directly Activated by Cyclic AMP 1/Ras-Related Protein 1 Axis.
    Aoyama M; Kawase H; Bando YK; Monji A; Murohara T
    Circ Heart Fail; 2016 Jan; 9(1):e002081. PubMed ID: 26721911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipeptidyl Peptidase-4 deficiency effectively protects the brain and neurological function in rodent after acute Hemorrhagic Stroke.
    Yip HK; Lee MS; Li YC; Shao PL; Chiang JY; Sung PH; Yang CH; Chen KH
    Int J Biol Sci; 2020; 16(16):3116-3132. PubMed ID: 33162819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice.
    Steven S; Jurk K; Kopp M; Kröller-Schön S; Mikhed Y; Schwierczek K; Roohani S; Kashani F; Oelze M; Klein T; Tokalov S; Danckwardt S; Strand S; Wenzel P; Münzel T; Daiber A
    Br J Pharmacol; 2017 Jun; 174(12):1620-1632. PubMed ID: 27435156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.